Bausch + Lomb (NYSE:BLCO) announced that its affiliate acquired AcuFocus, a privately held maker of ophthalmic medical devices. The deal remains pursuant to a merger transaction with the parent company of AcuFocus. Neither company disclosed the financial terms of the transaction. AcuFocus develops small aperture intraocular technology. Its portfolio includes the IC-8 Apthera intraocular lens […]
AcuFocus Inc.
FDA approves AcuFocus intraocular lens for cataract surgery
AcuFocus announced today that it received FDA approval for its IC-8 Apthera intraocular lens for the treatment of cataracts. Irvine, California-based AcuFocus said in a news release that the Apthera IOL represents the first and only non-toric, extended depth of focus IOL approved for the 82% of cataract patients who have as much as 1.5 […]
New eye health companies gain funders’ focus
Startups pioneering less-invasive technologies to treat common eye diseases are changing the outlook for both patients and the industry. A new study by CB Insights revealed that investors have been pouring money into smaller companies in 2017 and 2018, with some FDA approvals to begin marketing their technologies and treatments. These firms are eyeing conditions […]
SightLife Surgical to acquire AcuFocus Kamra corneal inlay
AcuFocus said yesterday it inked a deal with SightLife Surgical to divest itself of its AcuFocus Kamra corneal inlay designed for surgically treating presbyopia for an undisclosed amount. Irvine, Calif.-based AcuFocus said the Kamra inlay was the first such inlay to receive FDA approval designed for the surgical correction of presbyopia. “We believe this acquisition […]
AcuFocus raises $66m
AcuFocus, which makes the Kamra eye inlay for treating nearsightedness, said it raised $66 million in a new round of financing with funds slated to support accelerated commercialization of its products. The round was led by global investment firm KKR, Irvine, Calif.-based AcuFocus said. “We are honored that KKR has chosen to make AcuFocus its 1st investment […]
Former AcuFocus CEO Mazzo moves to head Ophthamology at Zeiss | Personnel Moves, July 28, 2016
Former AcuFocus CEO Mazzo moves to head Ophthamology at Zeiss Carl Zeiss Meditec (ETR:AFX) said this week it tapped ex-AcuFocus CEO James Mazzo as the global president of its ophthalmology business as well as managing the entire company’s U.S. sales and service center. Mazzo comes from a 3-year run as president and CEO at AcuFocus, where […]
AcuFocus raises $2m in new debt round
AcuFocus, which makes the Kamra eye inlay for treating nearsightedness, said it raised nearly $1.9 million in a round of debt funding. Irvine, Calif.-based AcuFocus said in a regulatory filing that the round included 14 unnamed investors. The company hopes to raise a total of $2.5 million, according to the filing. The company pulled in nearly $4.1 […]
AcuFocus raises $4m debt round
AcuFocus, which makes the Kamra eye inlay for treating nearsightedness, said it raised nearly $4.1 million in a round of debt funding. Irvine, Calif.-based AcuFocus said in a regulatory filing that the round included 16 unnamed investors. The company hopes to raise a total of $5 million, according to the filing. AcuFocus is backed by HealthCare […]
ABT unveils OTC glucose meter | Regulatory news for the week of April 20, 2015
FDA approves AcuFocus Kamra inlay
The FDA last week approved the 1st implant designed to correct near vision loss in patients who have not had cataract surgery, the Kamra inlay made by AcuFocus.
Mazzo suspended at Versant Ventures after insider trading indictment | Personnel Moves
Versant Ventures and James Mazzo agreed that Mazzo will "suspend any activities" at the venture capital shop following his indictment last month on insider trading charges.
